x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers

On a mission to disseminate information to the community and bridge the gap between academia and community oncology in this rapidly changing field of hematology & oncology. Drs. Rahul & Rohit Gosain interview world-renowned hematologists/oncologists to present the practice-changing data in a small bite-sized format where one could immediately apply that information in their daily practice to provide the best cancer care to their patients close to home. Privacy Policy:

health & fitness medicine

All Episodes

00:21:56

Exploring the role of targeted radiopharmaceutical...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/10/02

Welcome to the Oncology Brothers podcast! In this episode, we dive into the evolving landscape of neuroendocrine tumors (NETs) with guests Dr. Heloisa Soares, a medical oncologist, and Prof. Ken Herrmann, a nuclear medicine specialist. Together, we explored the role of Peptide Receptor Radionuclide Therapy (PRRT), imaging breakthroughs, and treatment sequencing to optimize outcomes for NET patients.We cover essential topics such as:•⁠ ⁠The role of Gallium-68 and Copper-64 DOTATATE PET imaging in

en

00:20:10

Challenging Cases of Venous Thromboembolism (VTE) -...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/09/29

Welcome to the Oncology Brothers podcast! In this episode we we deep into the complexities of venous thromboembolism (VTE) with Drs. Jennifer Vaughn and Nicolas Gallastegui Crestani from The Ohio State University. Join us as we explore real-life VTE scenarios, discussing both provoked and unprovoked events, treatment durations, and cancer-associated cases. We cover essential topics such as:•⁠ ⁠The workup for hypercoagulable states in young patients•⁠ ⁠Long-term anticoagulation strategies for

en

00:22:09

How to Treat Cutaneous Melanoma in 2025 - Dr. Omid Hamid

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/09/25

In this episode of the Oncology Brothers podcast, we are joined by Dr. Omid Hamid, a melanoma specialist from Cedars-Sinai, to explore the current treatment landscape of cutaneous melanoma.We covered a wide range of topics, including:•⁠ ⁠The standard of care for early-stage melanoma, including wide local excision and sentinel lymph node evaluation.•⁠ ⁠The role of adjuvant immunotherapy and BRAF/MEK inhibitors for high-risk patients.•⁠ ⁠Insights into neoadjuvant treatment options for resectable

en

00:17:24

Treatment Algorithm of Neuroendocrine Tumors (NET) in...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/09/22

Welcome to the Oncology Brothers podcast! In this episode, we dive deep into the world of neuroendocrine tumors (NETs) with renowned expert Dr. Thor Halfdanarson from the Mayo Clinic.Join us as we explore:•⁠ ⁠The critical factors in diagnosing NETs, including origin, grade, histological features, and Ki-67.•⁠ ⁠The importance of differentiating between functional and non-functional tumors and how this impacts treatment decisions.•⁠ ⁠Dr. Halfdanarson's treatment paradigm, including the use of

en

00:23:58

WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/09/18

Join us in this episode of the Oncology Brothers podcast as we dive into the highlights from the World Conference on Lung Cancer 2025! We are joined by Dr. Balazs Halmos, a thoracic medical oncologist at the Montefiore Einstein Cancer Center, to discuss three pivotal studies that are shaping the future of lung cancer treatment.In this episode, we covered:•⁠ ⁠FLAURA2 Trial: Discover the significant overall survival benefits of combining osimertinib with chemotherapy for patients with EGFR-positive

en

00:24:34

Treating and Managing Chronic Lymphocytic Leukemia...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/09/11

Join us for an insightful episode as we dive deep into the evolving landscape of Chronic Lymphocytic Leukemia (CLL) treatment. This episode features Dr. Mazyar Shadman, an expert in lymphoid malignancies from the Fred Hutch Cancer Center.In this episode, we covered:• The importance of shared decision-making in CLL treatment.• When to initiate treatment for newly diagnosed CLL patients.• The role of time-limited venetoclax-based regimens versus continuous BTK inhibitors.• Key considerations in

en

00:14:56

Managing Side Effects of New Treatments for Small...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/08/29

Welcome back to the Oncology Brothers podcast! In this episode, we continue the three-part CME series on small cell lung cancer, focusing on adverse events and management strategies for extensive stage small cell lung cancer treatments.We are thrilled to have Dr. Misty Shields from the Indiana University join us to discuss the latest advancements in treatment options following the exciting data presented at ASCO 2025. We dived into the treatment algorithm for patients with good performance status,

en

00:12:44

FDA Approval of Zongertinib for HER2 Mutated...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/08/25

Welcome back to the Oncology Brothers podcast! In this episode, Drs. Rohit & Rahul Gosain are joined by Dr. Joshua Sabari from the NYU Langone Cancer Center to discuss the exciting recent approval of Zongertinib, the first oral TKI for HER2-positive lung cancer.We dived deep into the prevalence of HER2 mutations in non-small cell lung cancer, the study design and findings from the Beamion LUNG-1 trial, and the implications of this new therapy in clinical practice. Dr. Sabari shared insights on

en

00:16:29

Latest Clinical Data for First-line Maintenance and...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/08/21

Welcome to the Oncology Brothers podcast! In this episode, we kick off a three-part CME series focused on small cell lung cancer (SCLC). Joined by Dr. Hossein Borghaei, Chief of Thoracic Oncology at the Fox Chase Cancer Center. Together they dived into the evolving treatment landscape for SCLC, highlighting recent advancements and data from ASCO 2025.Episode Highlights:•⁠ ⁠Overview of the current standard of care for limited and extensive-stage SCLC.•⁠ ⁠Discussion on the role of concurrent

en

00:22:21

FDA Approval of Datopotamab deruxtecan (Dato-DXd) in...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/08/18

In this episode of the Oncology Brothers podcast, Drs. Rohit & Rahul Gosain welcome Dr. Jacob Sands, a thoracic medical oncologist from the Dana-Farber Cancer Institute, to discuss the recent FDA approval of Dato-DXD (datopotamab deruxtecan) for previously treated EGFR-mutated non-small cell lung cancer (NSCLC).Key Topics:•⁠ ⁠Overview of Dato-DXd and its FDA approval•⁠ ⁠Mechanism of action and study design of the TROPION Lung trials•⁠ ⁠Efficacy and safety profile of Dato-DXd•⁠ ⁠Management of

en

00:17:55

Diagnosis and Treatment of Myelofibrosis with Dr....

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/08/11

Welcome to the Oncology Brothers podcast! In this episode, we continue our hematology series by diving deep into myelofibrosis (MF) with Dr. Raajit Rampal, an expert in myeloproliferative neoplasms from the Memorial Sloan Kettering Cancer Center.Join Drs. Rahul and Rohit Gosain as they discuss the latest updates in symptom management, emerging treatment combinations, and the importance of timely diagnosis and risk stratification for patients presenting with cytopenias and splenomegaly.Key topics

en

00:18:47

Managing Toxicities of TKIs and HIF-2 inhibitor in...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/08/07

Welcome back to the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by world-renowned medical oncologist Dr. Monty Pal from the City of Hope. Together, they dived deep into the management of side effects associated with tyrosine kinase inhibitors (TKIs) and HIF-2 alpha inhibitors used in treating renal cell carcinoma (RCC).Episode Highlights:• Understanding TKIs and HIF-2 Inhibitors: A discussion on the available oral treatment options for RCC, including

en

00:26:12

Myeloproliferative Neoplasms (MPN) Treatment:...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/08/04

In this episode of the Oncology Brothers podcast, Drs. Rahul and Rohit Gosain dived deep into the world of myeloproliferative neoplasms (MPNs), focusing specifically on polycythemia vera (PV) and essential thrombocythemia (ET). They are joined by Dr. Andrew Kuykendall, a hematologist from Moffitt Cancer Center, who shared his expertise on the latest treatment paradigms and risk stratification strategies for these conditions.Key topics discussed included:• The importance of ruling out secondary

en

00:11:29

Latest Advances in Tumor-Agnostic Strategies for NTRK...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/07/31

Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain, practicing community oncologists, share their key takeaways from a session on NTRK Fusion Positive Solid Malignancies, they moderated during a satellite event at ASCO 2025 in partnership with Medscape Global Oncology.Join us as we discuss:•⁠ ⁠The prevalence of NTRK fusions in various cancers and why community oncologists should be aware of them.•⁠ ⁠The importance of comprehensive next-generation sequencing

en

00:19:01

Challenging Cases with Relapsed/Refractory FLT3+...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/07/28

In this episode of the Oncology Brothers podcast, Drs. Rahul and Rohit Gosain dive into the complexities of relapsed refractory Acute Myeloid Leukemia (AML) with FLT3 mutations. Joined by leukemia specialists Dr. Uma Borate from the Ohio State University and Dr. Naval Daver from the MD Anderson Cancer Center, the discussion focused on real-life cases and the current standard of care for patients with FLT3-positive AML.Key topics included:•⁠ ⁠The importance of retesting for FLT3 mutations at the time

en

00:25:27

Treating Acute Myeloid Leukemia in 2025 - Induction,...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/07/24

In this episode of The Oncology Brothers, Drs. Rahul and Rohit Gosain are joined by Dr. Anand Patel, a hematologist and Medical Director of Inpatient Leukemia Service at the University of Chicago. Together, they delved into the complexities of acute myeloid leukemia (AML), one of the most aggressive cancers encountered in clinical practice.Episode Highlights:• Understanding the current standard of care for AML, including diagnosis and risk stratification.• The importance of molecular profiling and

en

00:22:18

Challenging Cases with Relapsed/Refractory Diffuse...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/07/21

Welcome to this episode of The Oncology Brothers! Drs. Rahul and Rohit Gosain dived into the complexities of relapsed refractory diffuse large B-cell lymphoma (DLBCL) with their new series focused on challenging real-life cases.In this episode, we are joined by esteemed guests Dr. Carla Casulo from Wilmot Cancer Center and Dr. Tara Graff from Mission Cancer and Blood Center. Together, we explored the current standard of care, including R-CHOP and the role of bi-specific antibodies like epcoritamab

en

00:21:35

How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/07/17

Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain dive deep into the world of diffuse large B-cell lymphoma (DLBCL), one of the most aggressive yet potentially curable lymphomas. We are joined by Dr. John Leonard, a renowned lymphoma expert from NYU Langone Cancer Center, who shares his insights on the latest data and evolving treatment landscape for DLBCL.Episode Highlights:•⁠ ⁠Understanding the initial workup for DLBCL, including the role of PET-CT and bone

en

00:20:30

How to Treat Early Stage Non-Small Cell Lung...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/07/10

In this episode of the Oncology Brothers podcast, Drs. Rahul and Rohit Gosain are joined by Dr. Deepa Rangachari, a thoracic medical oncologist and fellowship program director at Beth Israel Deaconess Medical Center. Together, they dived deep into the treatment algorithms for early-stage non-small cell lung cancer (NSCLC) with a focus on curative intent.Key topics discussed include:•⁠ ⁠The importance of staging and lymph node evaluation in treatment planning.•⁠ ⁠The role of neoadjuvant

en

00:18:16

ASCO 2025 - GU Cancer Highlights: KEYNOTE-564,...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2025/07/04

Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain, both practicing community oncologists, are joined by Dr. Tian Zhang from UT Southwestern to discuss key highlights from the ASCO 2025 annual meeting, focusing on genitourinary (GU) malignancies.Episode Highlights:• KEYNOTE-564: discussed 5 years OS data, reinforcing the role of adjuvant pembrolizumab in renal cell carcinoma• AMPLITUDE: combination of PARP inhibitor niraparib with abiraterone

en

195 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown